18th week of 2018 patent applcation highlights part 10 |
Patent application number | Title | Published |
20180116997 | METHODS OF INDUCING ANESTHESIA | 2018-05-03 |
20180116998 | USE OF CANNABIS TO TREAT FIBROMYALGIA, METHODS AND COMPOSITIONS THEREOF | 2018-05-03 |
20180116999 | METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS | 2018-05-03 |
20180117000 | ENERGY METABOLIC ACTIVATING AGENT FOR MUSCLE CELLS | 2018-05-03 |
20180117001 | Composition for Promoting Production of Brain-Derived Neurotrophic Factor | 2018-05-03 |
20180117002 | Taxane Analogs for the Treatment of Brain Cancer | 2018-05-03 |
20180117003 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING FATTY LIVER, PROTECTING LIVER FUNCTION OR AMELIORATING LIVER DISEASES CAUSED BY FATTY LIVER OR OTHER ASSOCIATED DISORDERS | 2018-05-03 |
20180117004 | SELECTIVE ABLATION OF PAIN-SENSING NEURONS BY ADMINISTRATION OF A VANILLOID RECEPTOR AGONIST | 2018-05-03 |
20180117005 | COMPOSITIONS FOR THE TREATMENT OF CANCER | 2018-05-03 |
20180117006 | ANTI-FUGETACTIC AGENT AND IMMUNOTHERAPY AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER | 2018-05-03 |
20180117007 | SMALL MOLECULE, INDIRUBIN-3-OXIME, FOR PREVENTION AND TREATMENT OF BONE DISEASE | 2018-05-03 |
20180117008 | Novel Formulation of Indomethacin | 2018-05-03 |
20180117009 | 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-Y- LIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE) | 2018-05-03 |
20180117010 | SHMT Inhibitors | 2018-05-03 |
20180117011 | ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER | 2018-05-03 |
20180117012 | Methods of Managing Pain Using Dexmedetomidine Transdermal Delivery Devices | 2018-05-03 |
20180117013 | METHODS OF TREATING LIVER DISEASE USING INDANE ACETIC ACID DERIVATIVES | 2018-05-03 |
20180117014 | METHODS OF INHIBITING LEUKOTRIENE A4 HYDROLASE | 2018-05-03 |
20180117015 | Targeting Metabolic Adaptive Responses to Chemotherapy | 2018-05-03 |
20180117016 | DEPOT FORMULATIONS | 2018-05-03 |
20180117017 | METHODS OF REVERSING AUTONOMIC NERVOUS SYSTEM DAMAGE | 2018-05-03 |
20180117018 | TREATMENT OF ZIKA VIRUS INFECTIONS USING ALPHA-GLUCOSIDASE INHIBITORS | 2018-05-03 |
20180117019 | BIOADHESIVE COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF GRANISTRON | 2018-05-03 |
20180117020 | LPT-723 AND IMMUNE CHECKPOINT INHIBITOR COMBINATIONS AND METHODS OF TREATMENT | 2018-05-03 |
20180117021 | COMPOUND OF 3-HYDROXYL PYRIDINE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | 2018-05-03 |
20180117022 | DEMETHYLPENCLOMEDINE ANALOGS AND THEIR USE AS ANTI-CANCER AGENTS | 2018-05-03 |
20180117023 | ORAL SOLID DOSAGE FORM OF AMLODIPINE AND VETERINARY USES THEREOF | 2018-05-03 |
20180117024 | METHODS FOR INHIBITING PRETERM LABOR AND UTERINE CONTRACTILITY DISORDERS AND PREVENTING CERVICAL RIPENING | 2018-05-03 |
20180117025 | TREATMENT METHOD BY COMBINED USE OF MDM2 INHIBITOR AND BTK INHIBITOR | 2018-05-03 |
20180117026 | COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS | 2018-05-03 |
20180117027 | USE OF NON-PEPTIDIC NK1 RECEPTOR ANTAGONISTS FOR THE PRODUCTION OF APOPTOSIS IN TUMOUR CELLS | 2018-05-03 |
20180117028 | COMPOSITIONS AND METHODS FOR TREATING DISEASES OF THE NAIL | 2018-05-03 |
20180117029 | Targeting Metabolic Vulnerability in Triple-Negative Breast Cancer | 2018-05-03 |
20180117030 | BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY | 2018-05-03 |
20180117031 | Crenolanib for Treating FLT3 Mutated Proliferative Disorders Associated Mutations | 2018-05-03 |
20180117032 | PHARMACOLOGICALLY ACTIVE COMPOUNDS | 2018-05-03 |
20180117033 | COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS | 2018-05-03 |
20180117034 | COMBINATION THERAPY FOR CANCER TREATMENT | 2018-05-03 |
20180117035 | Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazi- ne and salts thereof | 2018-05-03 |
20180117036 | ORAL PHARMACEUTICAL COMPOSITION FOR INCREASING HYPOXIA TOLERANCE | 2018-05-03 |
20180117037 | USE OF MASITINIB FOR TREATMENT OF AN AMYOTROPHIC LATERAL SCLEROSIS PATIENT SUBPOPULATION | 2018-05-03 |
20180117038 | TREATMENT OF OPHTHALMIC CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM THE EYE | 2018-05-03 |
20180117039 | COMBINATION THERAPY FOR TREATING PULMONARY HYPERTENSION | 2018-05-03 |
20180117040 | SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION | 2018-05-03 |
20180117041 | LIVER X RECEPTOR MODULATORS | 2018-05-03 |
20180117042 | METHODS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2018-05-03 |
20180117043 | USE OF SRC PROTEIN INHIBITOR IN THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS AND/OR TREATMENT OF ALZHEIMER'S DISEASE | 2018-05-03 |
20180117044 | BIHETEROARYL COMPOUNDS AND USES THEREOF | 2018-05-03 |
20180117045 | DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | 2018-05-03 |
20180117046 | ANTI-ULCERATIVE COLITIS COMPOUND | 2018-05-03 |
20180117047 | DRUG FOR PREVENTING AND/OR TREATING DEMENTIA | 2018-05-03 |
20180117048 | 6-AMINO-PURIN-8-ONE COMPOUNDS | 2018-05-03 |
20180117049 | METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION | 2018-05-03 |
20180117050 | METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION | 2018-05-03 |
20180117051 | METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION | 2018-05-03 |
20180117052 | COMBINATION THERAPIES FOR TREATING CANCERS | 2018-05-03 |
20180117053 | The Method of Use for Inhibitors of Epidermal Growth Factor Receptor Variants II, III and VI | 2018-05-03 |
20180117054 | STABLE CARFILZOMIB FORMULATIONS | 2018-05-03 |
20180117055 | USE OF PHOSPHOINOSITIDE 3-KINASE INHIBITORS FOR TREATMENT OF VASCULAR MALFORMATIONS | 2018-05-03 |
20180117056 | CONTROL OF PARASITIC INFECTION IN ANIMALS | 2018-05-03 |
20180117057 | COMPOSITION FOR INHIBITING GROWTH OR PROLIFERATION OF CHRONIC MYELOGENOUS LEUKEMIA CANCER STEM CELLS, AND SCREENING METHOD THEREFOR | 2018-05-03 |
20180117058 | SKIN-PENETRATING FORMULATION OF TAUROLIDINE | 2018-05-03 |
20180117059 | METHODS FOR TREATING EGFR MUTANT CANCERS | 2018-05-03 |
20180117060 | COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE | 2018-05-03 |
20180117061 | RATIONALE-BASED DESIGN OF A TARGETED THERAPY FOR CANCER | 2018-05-03 |
20180117062 | CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES | 2018-05-03 |
20180117063 | ORALLY DISINTEGRATING SOLID DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | 2018-05-03 |
20180117064 | AQUEOUS SUSPENSION AGENT CONTAINING GLUCOCORTICOSTEROID NANOPARTICLES | 2018-05-03 |
20180117065 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | 2018-05-03 |
20180117066 | System and Method for Diagnosis and Treatment | 2018-05-03 |
20180117067 | METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS | 2018-05-03 |
20180117068 | Stabilized Modified Release Vitamin D Formulation and Method of Administering Same | 2018-05-03 |
20180117069 | METHODS OF TREATMENT OF CANCER | 2018-05-03 |
20180117070 | ORAL CARE COMPOSITION | 2018-05-03 |
20180117071 | Cationic Polymers As Co-Drugs For Chemotherapeutic Agents | 2018-05-03 |
20180117072 | N-ACETYL MANNOSAMMINE AS A THERAPEUTIC AGENT | 2018-05-03 |
20180117073 | ANTISENSE COMPOUNDS TARGETING GENES ASSOCIATED WITH CYSTIC FIBROSIS | 2018-05-03 |
20180117074 | METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS | 2018-05-03 |
20180117075 | THERAPY FOR MALIGNANT DISEASE | 2018-05-03 |
20180117076 | MiRNA compositions for the treatment of mature B-cell neoplasms | 2018-05-03 |
20180117077 | GLYCOSAMINOGLYCAN ESTERS, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN FORMULATIONS FOR OPHTHALMIC USE | 2018-05-03 |
20180117078 | COMPOSITION AND METHOD TO ENHANCE EXPRESSION OF HUMAN DEFENSIN 2 | 2018-05-03 |
20180117079 | Methods And Compositions For Bowel Cleansing Before A Medical Procedure | 2018-05-03 |
20180117080 | COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS | 2018-05-03 |
20180117081 | PREPARATIONS FOR CONTROLLED-RELEASE OF HYPOCHLOROUS ACID | 2018-05-03 |
20180117082 | ANTIFUNGAL COMPOSITION/TREATMENT | 2018-05-03 |
20180117083 | COMPOSITIONS AND METHODS FOR COMBATING BACTERIAL INFECTIONS BY KILLING PERSISTER CELLS WITH MITOMYCIN C AND/OR CISPLATIN | 2018-05-03 |
20180117084 | METHODS FOR ENHANCING AN IMMUNE RESPONSE WITH A CTLA-4 ANTAGONIST | 2018-05-03 |
20180117085 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS | 2018-05-03 |
20180117086 | Device and Methods for Platelet Lysis or Activation | 2018-05-03 |
20180117087 | STEM CELLS FROM URINE AND METHODS FOR USING THE SAME | 2018-05-03 |
20180117088 | COMPOSITION FOR TREATING ARTICULAR CARTILAGE DEFECTS | 2018-05-03 |
20180117089 | ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT | 2018-05-03 |
20180117090 | Cell for Treating Neurodegenerative Disease, Pharmaceutical Compositions Containing Thereof, and Its Application | 2018-05-03 |
20180117091 | METHODS FOR TREATING MACULAR DEGENERATION | 2018-05-03 |
20180117092 | EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER OR IMMUNOLOGICAL DISEASES | 2018-05-03 |
20180117093 | MAPC TREATMENT OF BRAIN INJURIES AND DISEASES | 2018-05-03 |
20180117094 | EGG CHALAZA HYDROLYSATE, METHOD FOR PREPARING THE SAME AND USAGE OF THE SAME | 2018-05-03 |
20180117095 | COMPOSITION OF CHICKEN LIVER HYDROLYSATES AND METHOD FOR IMPROVING ALCOHOL METABOLISM, AS WELL AS PREVENTING AND TREATING LIVER FIBROSIS | 2018-05-03 |
20180117096 | METHOD FOR REDUCING METHANE PRODUCTION IN A RUMINANT ANIMAL | 2018-05-03 |